Answers are grounded in this paper and cite their sources.
The development of a target-activatable "smart" platform with high-affinity and specificity is of great importance for a wide range of biomedical applications. Here, we attempted to develop a new enzyme-activatable graphene oxide-photosensitizer complex as a biologically tunable theranostic agent, making it promising for near-infrared (NIR) fluorescence imaging and photo-induced cancer therapy.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: